Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 36
Diagnostic Pathology: Open Access received 36 citations as per Google Scholar report
Diagnostic Pathology: Open Access peer review process verified at publons
Indexed In
- Google Scholar
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- Euro Pub
- ICMJE
Useful Links
Share This Page
The Limitations Of Laboratory Medicine With Relevance To Biomarker Tests And Global Organ Disease
13th International Conference on Laboratory Medicine & Pathology
Ian James Martins
Edith Cowan University, Australia
Keynote: Diagn Pathol Open
Abstract
Various diagnostic technologies have been used with relevance to genomics, lipidomics and proteomics to allow more sensitive interpretations with relevance to early cell dysfunction. The diagnostic technologies encompass the genome, transcriptome, proteome and metabolome (central dogma of biology) and determine the cell genome (nuclear receptors) and transcription factor alterations with relevance to concentrations of plasma lipids and proteins. The projected cost of plasma and cell biomarker analysis is expected to be approximately 52 billion dollars by the year 2020. Major efforts with biomarkers have been identified with plasma protein panels to assess progression and severity of diseases. In spite of laboratory medicine and various analyte measurements for chronic diseases early abnormal nuclear-mitochondria interactions have not been identified with toxic immune reactions involved in mitochondrial apoptosis and the induction of programmed cell death.Biography
Dr. Ian Martins is a Reveiwer for international journals. Chief Editor for International Journal of Diabetes Research (2014-2017), Research and Reviews: Neuroscience (2016-2017), Journal of Diabetes and Clinical Studies. BIT Member (BIT Congress. Inc) with H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). Scientist for Science Advisory Board (USA)/Academic with Academia.edu. Citations > 3000. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name > 96% of the international SCIENTISTS. Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM.
E-mail: i.martins@ecu.edu.au
